4.4 Article

Validation of the Chinese version of the Coma Recovery Scale-Revised (CRS-R)

期刊

BRAIN INJURY
卷 33, 期 4, 页码 529-533

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/02699052.2019.1566832

关键词

Behavioral scale; Coma Recovery Scale-Revised; consciousness; unresponsive wakefulness syndrome; minimally conscious state

资金

  1. National Natural Science Foundation of China [81471100]
  2. National High Technology Research and Development Program of China (863 Program) [2015AA020514]
  3. Hangzhou Normal University [PD11002010002016]
  4. Research Fund for International Young Scientists of the National Natural Science Foundation of China [811247008]
  5. Medical Science and Technology Projects in Zhejiang Province [2013KYB213, 2015KYA181]
  6. College students in Zhejiang Province Science and Technology Innovation Activities plan [2017R423055]

向作者/读者索取更多资源

Primary Objective: This study aims to validate the Chinese version of the Coma Recovery Scale-Revised (CRS-R). Methods: One hundred sixty-nine patients were assessed with both the CRS-R and the Glasgow Coma Scale (GCS), diagnosed as being in unresponsive wakefulness syndrome (UWS, formerly known as vegetative state), minimally conscious state (MCS), or emergence from MCS (EMCS). A subgroup of 50 patients has been assessed twice by the same rater, within 24 h. Patient outcome was documented six months after assessment. Results: The internal consistency for the CRS-R total score was excellent (Cronbach's alpha = 0.84). Good test-retest reliability was obtained for CRS-R total score and subscale scores (intra-class correlation coefficient [ICC] = 0.87 and ICC = 0.66-0.84, respectively). Inter-rater reliability was high (ICC = 0.719; p < 0.01). Concurrent validity was good between CRS-R total scale and GCS total scale. Diagnostic validity was excellent compared with GCS (emerged from UWS: 24%; emerged from MCS: 28%). When considering patient outcome, diagnostic validity was good. In addition, false-positive rates have been detected for both diagnoses. Conclusion: The Chinese version of the CRS-R is a reliable and sensitive tool and can discriminate patients in UWS, MCS, and EMCS successfully.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据